ARCUTIS BIOTHERAPEUTICS INC. - COMMON STOCK
10,14
22-ноября-24 16:44:58
15 мин. задержка
Акции
-0,10
-0,98%
Сегодняшний диапазон
10,05 - 10,37
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
13 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update
06 ноя 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 ноя 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
24 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
23 окт 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
18 окт 2024 08:20:14 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 окт 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
25 сен 2024 01:00:00 Источник Nasdaq GlobeNewswire
-
24 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 сен 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
05 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
22 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
CORRECTION – Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 авг 2024 21:00:03 Источник Nasdaq GlobeNewswire
-
Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 авг 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 авг 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
01 авг 2024 16:00:00 Источник Nasdaq GlobeNewswire
-
Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.
29 июл 2024 07:35:00 Источник Nasdaq GlobeNewswire
-
Arcutis Launches ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis
29 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >